Download full-text PDF

Source
http://dx.doi.org/10.1038/bmt.2014.230DOI Listing

Publication Analysis

Top Keywords

development echinocandin
4
echinocandin resistance
4
resistance candida
4
candida krusei
4
krusei isolates
4
isolates exposure
4
exposure micafungin
4
micafungin caspofungin
4
caspofungin transplant
4
transplant unit
4

Similar Publications

Multidrug resistance in the pathogenic fungus Candida glabrata is a growing global threat. Here, we study mechanisms of multidrug resistance in this pathogen. Exposure of C.

View Article and Find Full Text PDF

Aloin remodels the cell wall of Candida albicans to reduce its hyphal virulence against oral candidiasis.

Appl Microbiol Biotechnol

January 2025

State Key Laboratory of Oral Diseases, National Center for Stomatology, National Clinical Research Center for Oral Diseases, West China School of Stomatology, Sichuan University, Chengdu, 610041, Sichuan, China.

Aloe vera (L.) Burm.f.

View Article and Find Full Text PDF

Genomic analyses reveal high diversity and rapid evolution of within a neonatal intensive care unit in Delhi, India.

Antimicrob Agents Chemother

January 2025

Medical Mycology Unit, Department of Microbiology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India.

causes life-threatening infections in immunocompromised hosts, including hospitalized neonates. This pathogen is intrinsically resistant to fluconazole, while uncommon strains resistant to multiple antifungal drugs, including voriconazole, amphotericin B, and echinocandins, have also been reported from healthcare environments. Thus, understanding how spread, persist, and adapt to healthcare settings could help us develop better infection management strategies.

View Article and Find Full Text PDF

Metabolic engineering of for high-level production of pneumocandin B.

Synth Syst Biotechnol

June 2025

Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education and School of Pharmaceutical Sciences, Wuhan University, 430072, Wuhan, China.

Pneumocandin B (PB) is a lipohexapeptide synthesized by and serves as the precursor for the widely used antifungal drug caspofungin acetate (Cancidas®). However, the low titer of PB results in fermentation and purification costs during caspofungin production, limiting its widespread clinical application. Here, we engineered an efficient PB-producing strain of by systems metabolic engineering strategies, including multi-omics analysis and multilevel metabolic engineering.

View Article and Find Full Text PDF

Background: This study assesses the impact of fluconazole resistance on 30-day all-cause mortality and 1-year recurrence in patients with Candida parapsilosis bloodstream infections (BSI).

Methods: A multicenter retrospective study was performed at 3 hospitals in Italy and Spain between 2018 and 2022. Adult patients with positive blood cultures for C.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!